top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

LRMR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $37,521,992.58

Insider Selling (Last 12 Months): $0.00

Larimar Therapeutics Insider Trading History Chart

Larimar Therapeutics Share Price & Price History

^$9.52

▲ +0.1 (1.06%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Larimar Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2024	James E Flynn	Director	Buy	4,290,617	$8.74	$37,499,992.58	6,151,406
2/14/2024	Frank E Thomas	Director	Buy	2,000	$11.00	$22,000.00	2,000
5/17/2023	Joseph Truitt	Director	Buy	2,750	$3.73	$10,257.50	2,750
5/17/2023	Michael Celano	CFO	Buy	5,000	$3.73	$18,650.00	112,746
9/16/2022	Michael Celano	CFO	Buy	31,746	$3.15	$99,999.90	31,746
9/16/2022	Thomas Edward Hamilton	Director	Buy	317,460	$3.15	$999,999.00	507,590
9/16/2022	Thomas Edward Hamilton	Director	Buy	317,460	$3.15	$999,999.00	507,590

NEW AI developed by trader who won 1,129% (in 2 days)

From Monument Traders Alliance | Ad

Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...

Click here to see how >>>

SEC Filings (Institutional Ownership Changes) for Larimar Therapeutics (NASDAQ:LRMR)

91.92% of Larimar Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Larimar Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	134,877	$0.98M	0.0%	+57.2%	0.211%
7/18/2024	Assenagon Asset Management S.A.	610,029	$4.42M	0.0%	-4.1%	0.956%
5/29/2024	Opaleye Management Inc.	174,413	$1.32M	0.3%	-72.0%	0.273%
5/20/2024	Virtu Financial LLC	17,578	$0.13M	0.0%	N/A	0.028%
5/17/2024	RA Capital Management L.P.	6,045,351	$45.88M	0.6%	N/A	9.475%
5/17/2024	Ikarian Capital LLC	438,528	$3.33M	0.4%	-27.3%	0.687%
5/16/2024	Janus Henderson Group PLC	4,020,965	$30.46M	0.0%	+52.2%	6.302%
5/15/2024	PEAK6 Investments LLC	12,500	$95K	0.0%	-58.3%	0.020%
5/14/2024	EntryPoint Capital LLC	13,927	$0.11M	0.1%	N/A	0.022%
5/14/2024	StemPoint Capital LP	740,877	$5.62M	1.5%	-5.4%	1.161%
5/10/2024	Vanguard Group Inc.	2,367,701	$17.97M	0.0%	+62.7%	3.711%
4/24/2024	Assenagon Asset Management S.A.	636,185	$4.83M	0.0%	N/A	0.997%
2/15/2024	Opaleye Management Inc.	623,500	$2.84M	0.8%	-26.5%	1.420%
2/14/2024	Verition Fund Management LLC	2,811,131	$12.79M	0.1%	-3.1%	6.402%
1/12/2024	SG Americas Securities LLC	14,159	$64K	0.0%	+27.3%	0.032%
11/15/2023	Adage Capital Partners GP L.L.C.	1,176,680	$4.65M	0.0%	+80.6%	2.719%
11/14/2023	Fred Alger Management LLC	116,269	$0.46M	0.0%	+22.5%	0.269%
11/14/2023	Pale Fire Capital SE	12,040	$48K	0.0%	N/A	0.028%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	21,835	$86K	0.0%	-54.6%	0.050%
11/13/2023	Acadian Asset Management LLC	35,947	$0.14M	0.0%	-71.7%	0.083%
11/7/2023	New York State Common Retirement Fund	6,663	$26K	0.0%	-77.6%	0.015%
10/20/2023	Golden State Equity Partners	23,800	$94K	0.0%	-18.8%	0.055%
10/13/2023	SG Americas Securities LLC	11,120	$44K	0.0%	N/A	0.026%
9/21/2023	Barclays PLC	54,232	$0.17M	0.0%	+91.7%	0.125%
8/22/2023	CHI Advisors LLC	3,414,468	$10.69M	3.2%	+24.3%	7.889%
8/15/2023	Journey Strategic Wealth LLC	35,260	$0.11M	0.0%	N/A	0.081%
8/14/2023	Prelude Capital Management LLC	19,013	$60K	0.0%	+49.7%	0.044%
8/7/2023	Acadian Asset Management LLC	127,227	$0.40M	0.0%	+73.3%	0.294%
8/4/2023	American International Group Inc.	12,345	$39K	0.0%	N/A	0.029%
6/1/2023	Prelude Capital Management LLC	12,700	$58K	0.0%	N/A	0.029%
6/1/2023	Golden State Equity Partners	29,300	$0.13M	0.1%	N/A	0.068%
5/16/2023	Great Point Partners LLC	900,000	$4.08M	0.8%	-29.3%	5.082%
5/11/2023	CHI Advisors LLC	2,746,265	$12.44M	3.3%	-20.9%	15.507%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	41,847	$0.19M	0.0%	+11.6%	0.236%
5/9/2023	Y Intercept Hong Kong Ltd	11,369	$52K	0.0%	N/A	0.064%
5/3/2023	Jump Financial LLC	16,200	$73K	0.0%	N/A	0.091%
5/1/2023	Virtu Financial LLC	32,185	$0.15M	0.0%	N/A	0.182%
2/14/2023	Verition Fund Management LLC	1,476,224	$6.10M	0.1%	+6.1%	8.336%
2/14/2023	683 Capital Management LLC	187,997	$0.78M	0.1%	-47.0%	1.062%
2/10/2023	Opaleye Management Inc.	1,560,000	$6.44M	2.2%	-6.1%	8.809%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	37,485	$0.16M	0.0%	+186.9%	0.212%
2/10/2023	Cheyne Capital Management UK LLP	63,680	$0.26M	0.5%	N/A	0.360%
2/6/2023	Fi3 FINANCIAL ADVISORS LLC	25,548	$0.11M	0.1%	-74.3%	0.144%
11/15/2022	Perceptive Advisors LLC	2,860,000	$9.15M	0.3%	N/A	16.149%
11/15/2022	Mangrove Partners	1,292,812	$4.14M	0.2%	+49.0%	7.300%
11/15/2022	Commodore Capital LP	750,000	$2.40M	0.4%	N/A	4.235%
11/14/2022	683 Capital Management LLC	354,928	$1.14M	0.1%	+42.7%	2.004%
11/14/2022	Point72 Asset Management L.P.	475,000	$1.52M	0.0%	N/A	2.682%
11/14/2022	Verition Fund Management LLC	1,391,336	$4.45M	0.1%	+244.5%	7.856%
11/14/2022	Altium Capital Management LP	320,000	$1.02M	0.4%	N/A	1.807%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	13,065	$42K	0.0%	N/A	0.074%
11/4/2022	Granite Point Capital Management L.P.	111,819	$0.36M	0.1%	N/A	0.631%
8/30/2022	Verition Fund Management LLC	403,890	$0.79M	0.0%	-4.9%	2.281%
8/15/2022	Opaleye Management Inc.	932,814	$1.83M	0.8%	-1.2%	5.267%
6/2/2022	Verition Fund Management LLC	424,599	$1.72M	0.0%	+80.0%	2.398%
5/17/2022	RA Capital Management L.P.	1,281,860	$5.19M	0.1%	-4.0%	7.238%
5/16/2022	Ghost Tree Capital LLC	100,000	$0.41M	0.1%	-55.6%	0.565%
2/16/2022	Ghost Tree Capital LLC	225,000	$2.43M	0.9%	+12.5%	1.270%
2/14/2022	Opaleye Management Inc.	883,602	$9.53M	2.0%	+6.1%	4.989%
2/14/2022	DAFNA Capital Management LLC	70,177	$0.76M	0.2%	+8.8%	0.396%
2/10/2022	Difesa Capital Management LP	52,450	$0.57M	0.4%	N/A	0.296%
11/16/2021	Janus Henderson Group PLC	641,115	$7.46M	0.0%	+6.7%	3.620%
11/16/2021	Opaleye Management Inc.	832,807	$9.60M	1.8%	+14.4%	4.702%
11/16/2021	Two Sigma Advisers LP	32,898	$0.38M	0.0%	N/A	0.186%
11/16/2021	Verition Fund Management LLC	79,656	$0.92M	0.0%	-67.4%	0.450%
11/16/2021	Citadel Advisors LLC	309,260	$3.57M	0.0%	+0.4%	1.746%
11/15/2021	Point72 Asset Management L.P.	196,896	$2.27M	0.0%	+98.6%	1.112%
11/15/2021	Marshall Wace LLP	26,587	$0.31M	0.0%	+8.5%	0.150%
11/12/2021	Renaissance Technologies LLC	246,274	$2.84M	0.0%	+25.8%	1.391%
11/12/2021	Geode Capital Management LLC	114,060	$1.32M	0.0%	+1.4%	0.644%
11/9/2021	BlackRock Inc.	241,867	$2.79M	0.0%	-4.0%	1.366%
11/4/2021	Asymmetry Capital Management L.P.	34,943	$0.40M	0.2%	N/A	0.197%
10/19/2021	Belvedere Trading LLC	22,954	$0.28M	0.0%	N/A	0.130%
8/25/2021	Marshall Wace LLP	24,494	$0.24M	0.0%	-54.7%	0.138%
8/18/2021	Ikarian Capital LLC	52,968	$0.52M	0.0%	-87.5%	0.299%
8/17/2021	Millennium Management LLC	257,868	$2.53M	0.0%	-27.1%	1.678%
8/17/2021	683 Capital Management LLC	256,620	$2.52M	0.1%	+16.6%	1.670%
8/17/2021	Boothbay Fund Management LLC	10,163	$100K	0.0%	-78.8%	0.066%
8/17/2021	Citadel Advisors LLC	308,143	$3.03M	0.0%	+2,391.1%	2.005%
8/16/2021	Point72 Asset Management L.P.	99,160	$0.97M	0.0%	+474.5%	0.645%
8/16/2021	Cubist Systematic Strategies LLC	3,250	$32K	0.0%	+78.5%	0.021%
8/16/2021	Opaleye Management Inc.	727,800	$7.15M	1.2%	N/A	4.736%
8/16/2021	State Street Corp	39,033	$0.38M	0.0%	N/A	0.254%
8/16/2021	Goldman Sachs Group Inc.	14,314	$0.14M	0.0%	N/A	0.093%
8/16/2021	Marshall Wace LLP	24,494	$0.24M	0.0%	-54.7%	0.159%
8/13/2021	Renaissance Technologies LLC	195,774	$1.92M	0.0%	-7.9%	1.274%
8/13/2021	Geode Capital Management LLC	112,454	$1.10M	0.0%	+10.9%	0.732%
8/13/2021	Vanguard Group Inc.	664,370	$6.53M	0.0%	+39.7%	4.323%
8/11/2021	BlackRock Inc.	251,900	$2.47M	0.0%	+10.0%	1.639%
8/11/2021	Ghost Tree Capital LLC	100,000	$0.98M	0.3%	N/A	0.651%
8/10/2021	Citigroup Inc.	13,718	$0.14M	0.0%	+185.1%	0.089%
8/4/2021	Fi3 FINANCIAL ADVISORS LLC	121,818	$1.22M	0.8%	+473.3%	0.793%
5/29/2021	Fi3 FINANCIAL ADVISORS LLC	21,248	$0.31M	0.3%	N/A	0.138%
5/21/2021	Citadel Advisors LLC	12,370	$0.18M	0.0%	N/A	0.080%
5/19/2021	Logos Global Management LP	230,000	$3.36M	0.3%	-67.8%	1.497%
5/18/2021	Millennium Management LLC	353,763	$5.17M	0.0%	+859.7%	2.302%
5/18/2021	Verition Fund Management LLC	229,301	$3.35M	0.0%	+86.3%	1.492%
5/18/2021	Orbimed Advisors LLC	617,245	$9.02M	0.1%	-30.4%	4.016%
5/18/2021	Cubist Systematic Strategies LLC	1,821	$27K	0.0%	N/A	0.012%
5/18/2021	Citadel Advisors LLC	12,370	$0.18M	0.0%	N/A	0.080%

Data available starting January 2016

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.

Today's Range

Now: $9.52

$9.34

$9.88

50 Day Range

MA: $8.55

$7.02

$10.68

52 Week Range

Now: $9.52

$2.18

$13.68

Volume

257,013 shs

Average Volume

565,606 shs

Market Capitalization

$607.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Larimar Therapeutics?: Larimar Therapeutics' top insider shareholders include:
James E Flynn (Director)
Thomas Edward Hamilton (Director)
Michael Celano (CFO)
Joseph Truitt (Director)
Frank E Thomas (Director)
Learn More about top insider investors at Larimar Therapeutics.
Who are the major institutional investors of Larimar Therapeutics?: Larimar Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.96%
Bank of New York Mellon Corp — 0.21%
Learn More about top institutional investors of Larimar Therapeutics stock.
Which institutional investors are selling Larimar Therapeutics stock?: In the last quarter, LRMR stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Which institutional investors are buying Larimar Therapeutics stock?: Within the last quarter, LRMR stock was bought by institutional investors including:
Bank of New York Mellon Corp
In the last year, these company insiders have bought Larimar Therapeutics stock:
James E Flynn (Director)
Thomas Edward Hamilton (Director)
Michael Celano (CFO)
Joseph Truitt (Director)
Frank E Thomas (Director)
Learn More investors buying Larimar Therapeutics stock.